# Pandemic Influenza Plasmid DNA Vaccines (Needle)

> **NCT00709800** · PHASE1 · COMPLETED · sponsor: **Vical** · enrollment: 56 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** VCL-IPT1
- **BIOLOGICAL:** VCL-IPT1
- **BIOLOGICAL:** VCL-IPT1
- **BIOLOGICAL:** VCL-IPM1
- **BIOLOGICAL:** PBS

## Key facts

- **NCT ID:** NCT00709800
- **Lead sponsor:** Vical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-09
- **Final completion:** —
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2009-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709800, "Pandemic Influenza Plasmid DNA Vaccines (Needle)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00709800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*